2014-01-23 18:36:01 - Global Testosterone Market 2012-2016 - a new market research report on companiesandmarkets.com
The Global Testosterone market is to grow at a CAGR of 26.26 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population across the globe. The Global Testosterone market has also been witnessing an increasing number of R&D activities that are focused on developing testosterone replacement therapies. However, the entry of generics could pose a challenge to the growth of this market.
Numerous well-known vendors have increased their focus and efforts in R&D toward the development of testosterone replacement products that are more effective, have fewer side effects, and have more potential to enhance testosterone levels. Restoring testosterone levels to normal range improves quality of life in the long term and
is beneficial in providing the patient with a range of benefits to his/her muscle and bone and other testosterone-dependent functions. Restoring testosterone levels also increases the body-mass index of the patient. Although testosterone replacement therapies replace the hormone in the body, no study has been conducted to see if the same therapy helps reduce the occurrence of fractures and if the therapy would be able to reach a level of clinical significance. Thorough investigations have not been conducted to ascertain the threshold serum testosterone level needed to avoid morbidity or its correlation with age. Continuous efforts are being made to explore these arenas, which could lead to the development of new and more effective drugs.
One of the main drivers of this market is the increasing global aging population. The number of patients suffering from testosterone deficiency is increasing due to its relatively high prevalence in the elderly population.
One of the major challenges affecting the market growth is the entry of generic drugs. The introduction of generic drugs will lead to price wars among vendors and to price erosion. The patent expiry of leading brands will also significantly impact the growth of the market during the forecast period. This will lead to considerable losses for the manufacturing and marketing vendors and inhibit the growth of the market as the prices of the drugs need to be reduced considerably.
The key vendors dominating this space include AbbVie Inc., Auxilium Pharmaceuticals Inc., Actavis Inc., Eli Lilly & Co., and Endo Health Solutions Inc.
The other vendors mentioned include Actient Pharmaceuticals LLC, Acrux Ltd., Bayer Schering Pharma AG, BioSante Pharmaceuticals Inc., GlaxoSmithKline plc, Kyowa Hakko Kirin Co. Ltd., Pfizer Inc., Teva Pharmaceuticals Industries Ltd., and Trimel BioPharma SRL.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.